Dan Sheng
Directeur/Membre du Conseil chez BEIJING STRONG BIOTECHNOLOGIES,INC.
Fortune : 907 594 $ au 30/04/2024
Postes actifs de Dan Sheng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Directeur/Membre du Conseil | 13/08/2020 | - |
| Corporate Officer/Principal | 01/12/2016 | - | |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Directeur/Membre du Conseil | 30/09/2020 | - |
Historique de carrière de Dan Sheng
Formation de Dan Sheng
| University of Science & Technology of China | Undergraduate Degree |
| New York University | Doctorate Degree |
| The University of Chicago | Masters Business Admin |
Statistiques
Internationale
| Chine | 4 |
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
